Company intelligence / Profile preview

Juzen Chemical Corporation

Ownership: Private
Employees: ~322
Development stage: Commercial

Overview

Juzen Chemical Corporation is an established Japanese CDMO/CMO specializing in contract manufacturing of APIs, key intermediates, highly potent APIs, and oligonucleotides. The company has multiple US FDA audit records for its facilities and GMP systems. It offers services from R&D to commercial-scale manufacturing for pharmaceutical clients globally[1][4][5].

Therapeutic areas: Other
Modalities: Small moleculesOligonucleotidesHighly potent APIs (Active Pharmaceutical Ingredients)
Industry: Contract Manufacturing Organization

Partnerships

Not specifically listed in public sources. As a CDMO/CMO/CRO, the company likely partners with various pharmaceutical companies on client projects but no major named partnerships are disclosed[1][4]

Beyond the preview

Go deeper on Juzen Chemical Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Juzen Chemical Corporation.

Explore the full profile